Palisade Bio Inc (PALI)

Name: Palisade Bio Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-03-31

Latest Quarter

2025-03-31

Revenue

$0.0

Net Income

-$2.2M

Operating Margin

N/A

Free Cash Flow

-$12.2M

Debt / Assets

31.1%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Palisade Bio Inc (PALI).
Income Statement (Quarterly)	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Revenue	0	0	0	0
Cost of Revenue	0	0	0	1,000
Gross Profit	0	0	0	-1,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,360,000	1,298,000	1,456,000	1,583,000
Operating Expenses	2,310,000	3,382,000	3,593,000	4,211,000
Operating Income	-2,310,000	-3,382,000	-3,593,000	-4,211,000
Interest Expense	-1,000	3,000	6,000	2,000
Income Before Tax	-2,230,000	-3,344,000	-3,487,000	-4,080,000
Income Tax Expense	0	0	0	0
Net Income	-2,230,000	-3,344,000	-3,487,000	-4,080,000
Per Share
EPS	-0.47	-0.57	-2.32	-3.32
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Palisade Bio Inc (PALI).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	0	0	250,000	0	0
Cost of Revenue	3,000	0	4,000	167,000	0
Gross Profit	-3,000	0	250,000	-167,000	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	7,864,000	5,796,000	6,202,000	8,764,000	9,307,000
Operating Expenses	18,056,000	14,859,000	13,320,000	15,311,000	41,854,000
Operating Income	-18,056,000	-14,859,000	-13,070,000	-15,721,000	-41,854,000
Interest Expense	10,000	0	15,000	13,000	-2,398,000
Income Before Tax	-16,781,000	-14,438,000	-12,300,000	-14,260,000	-26,616,000
Income Tax Expense	0	0	0	-1,461,000	0
Net Income	-16,781,000	-14,438,000	-12,300,000	-12,799,000	-26,616,000
Per Share
EPS	-0.30	-2.48	-27.01	-14.54	-109.92
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Palisade Bio Inc (PALI).
Balance Sheet (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	9,821,000	12,432,000	12,383,000	10,495,000
Short Term Investments	0	0	0	0
Net Receivables	24,000	148,000	1,438,000	0
Inventory	0	0	-1,438,000	0
Total Current Assets	10,494,000	13,216,000	14,733,000	12,374,000
Property Plant Equipment	87,000	208,000	310,000	112,000
Goodwill and Intangibles	0	0	0	0
Total Assets	10,880,000	14,052,000	15,763,000	12,512,000
Liabilities
Account Payables	1,105,000	698,000	1,828,000	1,323,000
Short Term Debt	169,000	279,000	193,000	199,000
Total Current Liabilities	3,236,000	2,586,000	3,012,000	2,496,000
Long Term Debt	0	90,000	211,000	0
Total Liabilities	3,388,000	2,739,000	3,284,000	5,147,000
Shareholders Equity
Retained Earnings	-135,944,000	-121,506,000	-109,190,000	-94,642,000
Total Shareholders Equity	7,492,000	11,313,000	12,479,000	7,365,000

Balance sheet annual history for Palisade Bio Inc (PALI).
Balance Sheet (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets
Cash and Cash Equivalents	9,821,000	12,432,000	12,383,000	10,495,000	10,529,244
Short Term Investments	0	0	0	0	0
Net Receivables	24,000	148,000	1,438,000	0	0
Inventory	0	0	-1,438,000	0	0
Total Current Assets	10,494,000	13,216,000	14,733,000	12,374,000	12,880,796
Property Plant Equipment	87,000	208,000	310,000	112,000	10,776
Goodwill and Intangibles	0	0	0	0	0
Total Assets	10,880,000	14,052,000	15,763,000	12,512,000	12,891,572
Liabilities
Account Payables	1,105,000	698,000	1,828,000	1,323,000	649,345
Short Term Debt	169,000	279,000	193,000	199,000	0
Total Current Liabilities	3,236,000	2,586,000	3,012,000	2,496,000	3,205,930
Long Term Debt	0	90,000	211,000	0	0
Total Liabilities	3,388,000	2,739,000	3,284,000	5,147,000	3,281,228
Shareholders Equity
Retained Earnings	-135,944,000	-121,506,000	-109,190,000	-94,642,000	0
Total Shareholders Equity	7,492,000	11,313,000	12,479,000	7,365,000	9,767,916

Cash flow quarterly history for Palisade Bio Inc (PALI).
Cash Flow Statement (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-14,438,000	-12,316,000	-14,260,000	-26,616,000
Depreciation & Amortization	3,000	4,000	3,000	0
Stock Based Compensation	652,000	624,000	1,032,000	0
Change in Working Capital	1,391,000	400,000	1,250,000	-4,756,000
Operating Cash Flow	-12,193,000	-11,133,000	-13,360,000	-14,773,000
Investing Activities
Capital Expenditure	0	-4,000	-10,000	0
Investments	0	-4,000	-10,000	0
Investing Cash Flow	0	-4,000	-10,000	-54,000
Financing Activities
Debt Repayment	-426,000	-391,000	-790,000	0
Common Stock Issued/Repurchased	8,446,000	11,594,000	14,401,000	0
Dividends Paid	0	0	0	0
Financing Cash Flow	9,582,000	11,186,000	15,258,000	24,609,000
Summary
Free Cash Flow	-12,193,000	-11,137,000	-13,370,000	-14,773,000
Net Change in Cash	-2,611,000	49,000	1,888,000	0

Cash flow annual history for Palisade Bio Inc (PALI).
Cash Flow Statement (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Operating Activities
Net Income	-14,438,000	-12,316,000	-14,260,000	-26,616,000	-16,266,820
Depreciation & Amortization	3,000	4,000	3,000	0	92,272
Stock Based Compensation	652,000	624,000	1,032,000	0	584,991
Change in Working Capital	1,391,000	400,000	1,250,000	-4,756,000	2,389,000
Operating Cash Flow	-12,193,000	-11,133,000	-13,360,000	-14,773,000	-9,025,129
Investing Activities
Capital Expenditure	0	-4,000	-10,000	0	0
Investments	0	-4,000	-10,000	0	0
Investing Cash Flow	0	-4,000	-10,000	-54,000	0
Financing Activities
Debt Repayment	-426,000	-391,000	-790,000	0	0
Common Stock Issued/Repurchased	8,446,000	11,594,000	14,401,000	0	11,150,318
Dividends Paid	0	0	0	0	0
Financing Cash Flow	9,582,000	11,186,000	15,258,000	24,609,000	14,465,916
Summary
Free Cash Flow	-12,193,000	-11,137,000	-13,370,000	-14,773,000	-9,025,129
Net Change in Cash	-2,611,000	49,000	1,888,000	0	5,439,602